With the merger, which will undoubtedly go through, the number of shares outstanding is approximately 30 million. Unlike most biotech companies, the merged company actually has revenues, 17.5 million and about 7 million in cash. The Phase Ib results were very impressive and the market they are looking to serve is a billion dollar market. The P value demonstrates that the results were unlikely random. Of course the patient population was small and it was single site subject to investigator bias but the company will explain more about that on Monday after the close. Regardless, the data is extremely impressive and for this reason they holding a CC on Monday after the close. Just based on the P1b results the company should have a market cap of 100 million similar to peers or about 3.30 a share. Prior to the merger, ThermoGenesis was trading at it's lows around a dollar. Through the dollar on top of the 3.30 and you are at 4.30. This says nothing about the pipeline and the underlying business. Look for a run to 4 dollars next week.
One I am not a doctor and neither are most of you. It is easy to reiterate the company narrative. It is better to follow the money. See what happens tomorrow. It is setting up for another dump day. If volume comes in and they take it higher I would jump on board. But I think the "smart" money is getting out before the results. Look for 5.45 as support as that is the 50 day. If it breaks that then 4 bucks. Strange nest ce pas that it is down another 5% AH? Secondary coming? I don't know. I just know it looks broken for now